


#OpenAccess Urology journal. Supporting #SoundScience & guiding readers towards excellence. Editor: @michael_gorin Impact Factor: 1.6




Online now: Current attitudes to testicular prosthesis insertion during radical orchidectomy—An international perspective @AnthonyE247 @NikitaB0709 @veerukasi doi.org/10.1002/bco2.465

November's issue of BJUI Compass is online now! bjui.pub/BJUI-Compass-Curren…

Hot off the press - just published in @BJUICompass - comparison of WATER 1 (30-80cc) vs WATER 2 (80-150cc) surgical outcomes. Even in beginners hands back in 2016-17 & no focal cautery.... same outcomes @PROCEPTRobotics #Aquablation #BPH surgery. dx.doi.org/10.1002/bco2.430

Online now: Targeted microwave ablation of localised #ProstateCancer: Initial results of VIOLETTE trial doi.org/10.1002/bco2.444

Accuracy of warm ischemia time measurement using a surgical intelligence software in partial #nephrectomies: A validation study @KhandekarArchan @dsui_miami_uro @dipenjparekh @joaogsporto doi.org/10.1002/bco2.452

Patients and generative AI: Who owns your diagnosis? #AI #ethics #policy #law @AsherMandel27 @nycrobotics doi.org/10.1002/bco2.420

A sustainable and expedited ‘One-Stop’ #ProstateCancer diagnostic pathway to reduce environmental impact and enhance accessibility @lorenzormc @KanekoMasatomo @ALDCAbreu @Urology_AI doi.org/10.1002/bco2.447

Our last paper just released @BJUICompass Several advantages on using PrecisionPoint Transperineal Access System: -more precise and higher quality biopsies -less local anesthesia -faster learning curve @luca_orecchia @BXTA_ @PNLogic bjui-journals.onlinelibrary.…

Just published: Sequencing the Barcelona-MRI predictive model and Proclarix for improving the uncertain PI-RADS 3 @enrique_trilla doi.org/10.1002/bco2.448

Early oncological outcomes of delayed radical prostatectomy: A prospective, international, follow-up analysis of the @CovidSurg Cancer study @BURSTurology @ArjunSNathan @veerukasi doi.org/10.1002/bco2.433

Understanding the long-term impact of the COVID-19 pandemic on non-muscle-invasive #BladderCancer outcomes: 12-Month follow-up data from the international, prospective @CovidSurg Cancer study @veerukasi @CamEAlexander @BURSTurology doi.org/10.1002/bco2.432

Treatment preferences of patients with muscle invasive #BladderCancer: A discrete choice experiment @MrLMannion doi.org/10.1002/bco2.443

Indian consensus statements on the management of small renal masses, non-muscle invasive #BladderCancer and high-risk/locally advanced #ProstateCancer @usioffice @DrSimon_UroOnc @nairajesh @bhav_lad @prokarurol @DrAmitGhose doi.org/10.1002/bco2.440